Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
University of Colorado researchers target earlier diagnosis and treatment resistance with cutting-edge technology.
Two new gene-editing therapies may offer a functional cure, but cost and access issues could limit their use.
Novel treatment relies on a newer form of CRISPR gene-editing technology called base editing.
A Damon Runyon scientist investigates the role of aneuploidy, or abnormal chromosome number, in cancer—and in possible treatments.
New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma.
Researchers found a new gene, ZFP36L1, that hasn’t been studied in association with small-cell lung cancer and the protein LSD1.
Researchers better understand how a SHOC2 protein structure plays a part in mutations in RAS genes, which often drive tumor growth.
Watch groundbreaking scientists share their experiences and explain how Damon Runyon funding makes a difference in cancer research.
Damon Runyon Cancer Research Foundation Fellows are mapping the genetics of DNA repair, with implications for cancer research.
Researchers looking at ovarian cancer cells that resist chemotherapy hope to develop new therapeutic strategies.
The gene-editing tool can alter the DNA of human cells like a precise pair of scissors.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
This mix-up may help explain why cancer drugs aren’t always as effective as hoped.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
The new method may increase gene editing efficiency and safety for future use in human cells.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.